Welch Slams Big Pharma for Spreading Fear

154

BURLINGTON, Vt. – Vermont’s junior senator, Peter Welch, criticizes big pharma following the White House’s announcement of drug price negotiations, stating that pharmaceutical companies are resorting to fear mongering tactics. This news comes as part of the ongoing discussions about the Inflation Reduction Act.

These negotiations are part of the Inflation Reduction Act and aim to reduce prescription drug prices for seniors. Welch believes that pharmaceutical companies are taking advantage of American’s concerns over healthcare costs.

“These companies are preying on the fears of the public, claiming their innovations are at risk due to these price negotiations. They are exploiting people’s worry about the health and well-being of their loved ones,” said Welch in a recent press statement.

Under the Inflation Reduction Act, up to 60 medication prices can be negotiated by Medicare. The initial round of negotiations includes insulin and heart disease medication prices. This move is expected to benefit seniors who rely on these essential medications.

Read More US Economic News